Agomab Therapeutics
Antwerp, BE · 6 known investors
Agomab Therapeutics is a clinical-stage biopharmaceutical company developing small molecule inhibitors targeting fibro-inflammation, with a focus on treating fibrotic diseases including Fibrostenosing Crohn's Disease and Idiopathic Pulmonary Fibrosis.
Founders & leadership
TK
Tim KnotnerusChief Executive Officer